Ignite Creation Date:
2024-05-06 @ 10:59 AM
Last Modification Date:
2024-10-26 @ 12:38 PM
Study NCT ID:
NCT03403712
Status:
COMPLETED
Last Update Posted:
2020-06-01
First Post:
2018-01-04
Brief Title:
A Study to Assess the Safety and the Efficacy of IV FosnetupitantPalonosetron 260 mg025 mg Combination Compared to Oral NetupitantPalonosetron 300 mg05 mg Combination for the Prevention of CINV in AC Chemotherapy in Women With Breast Cancer
Sponsor:
Organization:
Helsinn Healthcare SA
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
404
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE3 |
Observational Models:
Time Perspective List:
Who Masked List: